ArticleGMS infectious diseases2025

Response to: Methodological and ethical considerations in evaluating centralized COVID-19 drug procurement: a letter to the editor.

Kathrin Marx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.